GEMTUZUMAB OZOGAMICIN
gemtuzumab ozogamicin 5 mg injection, 1 vial
GEMTUZUMAB OZOGAMICIN (12904E)
12904E
Manner of administration:Injection
Restriction
Indication: Acute Myeloid Leukaemia
Treatment phase: Consolidation treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 5 mg | # of repeats: 1 | DPMA: $9,432.24 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Mylotarg
(gemtuzumab ozogamicin 5 mg injection, 1 vial)
|
||||